title: [Comments on the guidelines of the French-Language Society of Pneumology on the use of serum tumor markers in the management of primary bronchial cancers. Restatement].
authors.forename: N
authors.initials: N
authors.lastname: Roche
authors.forename: H
authors.initials: H
authors.lastname: Lioté
authors.forename: B
authors.initials: B
authors.lastname: Housset
mesh_terms: D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis*; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D015272:Pulmonary Medicine; D012955:Societies, Medical
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins